Sorin gets CE mark approval for Solo Smart,the evolution of Freedom Solo, a stentless and biological aortic valve with no synthetic material, proven outstanding hemodynamic and clinical performance.
Approval/Clearance
Tensyn™ Band 510(k) For Syndesmosis Repair: Come on Dallen, Show Us Your Wares
Back in July, Dallen Medical submitted its 510(k) for the Tensyn™ band for fixation of ankle syndesmosis. Now the company is reporting that the FDA has duly cleared the product for market.
US and EU Nods for Boston Scientific’s Direxion™ Torqueable Microcatheter
Boston Scientific’s FDA cleared and CE mark approved new embolectomy catheter features a proprietary shaft design that the company says enables better control In hard-to-navigate Vessels.
FDA Approval Brings New Treatment Option for Uncontrolled Epilepsy
Neuro implant developer, NeuroPace has announced the U.S. FDA approval of its RNS Stimulator, a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.
Newly CE Marked Tissue Damage Detector Launched at Medica
Bruin Biometrics, LLC has gained CE Mark approval to market the SEM Scanner in the European Union. The SEM Scanner is that is intended to detect localized tissue edema and pressure induced tissue damage that may lead to the formation of pressure ulcers before damage becomes visible on the skin’s surface.
CE Mark for ReliantHeart HeartAssist5® Ventricular Assist Device
The ReliantHeart HeartAssist 5®Ventricular Assist Device (VAD) has gained CE Mark approval in Europe for use in patients requiring ventricular support due to end stage heart failure. The HeartAssist 5® is approved for bridge to transplant (BTT) patients awaiting cardiac transplantation and for destination therapy (DT) patients who are not candidates for cardiac transplantation.
CE Mark for Avedro’s KXL II ™ Non-Surgical Myopia Correction System
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, has gained CE Mark clearance for its KXL II System, building on the company’s portfolio of technologies aimed at non-surgical correction of ophthalmic conditions.
Medtronic’s Software Gains FDA Nod for Use in Detecting ICD Lead Issues with Non-Medtronic Leads
Medtronic’s Lead Integrity Alert software is designed to detect implantable pacing lead failures better than impedance monitoring alone. Now the company has gained FDA approval for its system to be used in the detection of problems with other manufacturers’ leads, which opens up a further 12,000 case in the US alone.
Veniti(TM) Hopes Newly CE Marked Vici(TM) Venous Stent Will Conquer Venous Obstruction
Veniti™, Inc., has received approval to CE Mark the Veniti Vici™ Venous Stent, specifically designed for the treatment of venous obstruction. In addition, the company received CE Mark approval for their varicose vein ablation product, the Veniti Veni™ RF Plus Ablation System.
CE Marking Means Gore Has Endovascular Treatment Option for Iliac Artery Aneurysms
W. L. Gore & Associates has gained CE Mark approval for its GORE EXCLUDER Iliac Branch Endoprosthesis. The company says Excluder is the first complete, fully engineered system intended for endovascular treatment of common iliac artery aneurysms or aorto-iliac aneurysms.
Biotronik’s PK Papyrus Covered Coronary Stent CE Marked for Acute Coronary Artery Perforation
Biotronik has seen its clever, electrospun coated stent gain CE mark approval for use in cases of acute coronary vessel perforation. The clever part lies in the electrospinning, which creates a single, integrated coating without the need to sandwich the stent.
US FDA approval for Novo Nordisk’s Pre-filled Insulin Pens
Diabetes solutions giant Novo Nordisk, has gained FDA approval for its pre-filled insulin pens which it says avoid the patient challenges presented by other pre-filled pens.
ReVerse® 21 and 27 Neurovascular Microcatheters Break Cover Globally
Its been a good week for Reverse Medical Corporation, which has seen CE Mark approval, FDA 510k clearance and initial clinical use of its ReVerse® Microcatheter product line for intracranial neurovascular use.
Abbott Gets Timing Right with Mitraclip® Approval and New Clinical Support at TCT2013
FDA’s Mitraclip approval now means it’s available in the United States for patients with significant symptomatic degenerative MR who are at prohibitive risk for mitral valve surgery. New data at TCT2013 provides compelling clinical support for the device in this patient group.
FDA Clears Neurovent®-PTO: Single Neuro Catheter Monitors 3 Parameters-Brain Tissue pti02, ICP and ICT
Neuromonitoring device company Raumedic has gained FDA 510(k) clearance to market Neurovent®-PTO. The company says this is the only marketed device that combines measurement of intracranial pressure , intracranial temperature and oxygen partial pressure in one Catheter.
FDA Clearance for NLT Spine’s TLIF System
MIS spine developer NLT Spine, has seen two of its generation 2.0 products designed for spinal fusion procedures received FDA 510(k) clearance. PROW FUSION™ and eSPIN™ both target the lumbar interbody fusion market, which currently represents an opportunity of approximately $1.3 billion globally.